A. Henriques

发表

Ambroxol Hydrochloride Improves Motor Functions and Extends Survival in a Mouse Model of Familial Amyotrophic Lateral Sclerosis

M. Spedding, J. Loeffler, Alexandra Bouscary, 2019, Front. Pharmacol..

CNS-targeted viral delivery of G-CSF in an animal model for ALS: improved efficacy and preservation of the neuromuscular unit.

Tanjew Dittgen, M. Klugmann, A. Schneider, 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

Granulocyte-colony stimulating factor improves outcome in a mouse model of amyotrophic lateral sclerosis

Tanjew Dittgen, Friederike Kirsch, H. Ehrenreich, 2008, Brain : a journal of neurology.

Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis

M. Spedding, C. Andres, D. Priestman, 2017, Scientific Reports.

Can Transcriptomics Cut the Gordian Knot of Amyotrophic Lateral Sclerosis?

A. Henriques, J. González de Aguilar, 2011, Current genomics.

Gene expression changes in spinal motoneurons of the SOD1G93A transgenic model for ALS after treatment with G-CSF

N. Gretz, Friederike Kirsch, A. Schneider, 2015, Front. Cell. Neurosci..

Systemic Down-Regulation of Delta-9 Desaturase Promotes Muscle Oxidative Metabolism and Accelerates Muscle Function Recovery following Nerve Injury

J. Loeffler, A. Henriques, E. Marchioni, 2013, PloS one.

Degeneration of serotonergic neurons in amyotrophic lateral sclerosis: a link to spasticity.

K. Lesch, V. Meininger, A. Echaniz-Laguna, 2013, Brain : a journal of neurology.

Drug repositioning in neurodegeneration: An overview of the use of ambroxol in neurodegenerative diseases.

M. Spedding, J. Loeffler, Alexandra Bouscary, 2020, European journal of pharmacology.

Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis

M. Spedding, C. Boursier-Neyret, J. Loeffler, 2018, Front. Mol. Neurosci..

Blood Cell Palmitoleate-Palmitate Ratio Is an Independent Prognostic Factor for Amyotrophic Lateral Sclerosis

A. Echaniz-Laguna, C. Andres, P. Corcia, 2015, PloS one.

Profound lipid dysregulation in mutant TDP-43 mice is ameliorated by the glucocerebrosidase 2 inhibitor ambroxol

M. Spedding, J. Loeffler, A. Henriques, 2022, bioRxiv.

NX210c Peptide Promotes Glutamatergic Receptor-Mediated Synaptic Transmission and Signaling in the Mouse Central Nervous System

N. Callizot, A. Henriques, Y. Godfrin, 2022, International journal of molecular sciences.

Muscle cells of sporadic amyotrophic lateral sclerosis patients secrete neurotoxic vesicles

V. Meininger, F. Salachas, D. Devos, 2022, Journal of cachexia, sarcopenia and muscle.

Muscle cells of sporadic ALS patients secrete neurotoxic vesicles

V. Meininger, F. Salachas, D. Devos, 2021, medRxiv.

Characterization of a Novel SOD-1(G93A) Transgenic Mouse Line with Very Decelerated Disease Development

A. Schneider, A. Henriques, C. Pitzer, 2010, PloS one.

Analytical sequence to study G-CSF effect on the transcriptome of isolated spinal motoneurons from SOD1 G93A mice, an animal model for amyotrophic lateral sclerosis

A. Schneider, A. Henriques, Oliver Wafzig, 2015, Genomics data.

Alpha-Synuclein: The Spark That Flames Dopaminergic Neurons, In Vitro and In Vivo Evidence

P. Poindron, N. Callizot, A. Henriques, 2022, International journal of molecular sciences.

Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing

Michael R. Duchen, Ralph A. Nixon, Erwan Bezard, 2018, Nature Reviews Drug Discovery.

Sphingolipids metabolism alteration in the central nervous system: Amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

M. Spedding, J. Loeffler, Alexandra Bouscary, 2020, Seminars in cell & developmental biology.

AZP2006, a new promising treatment for Alzheimer’s and related diseases

P. Verwaerde, N. Callizot, A. Henriques, 2021, Scientific Reports.

Neurotrophic Growth Factors for the Treatment of Amyotrophic Lateral Sclerosis: Where Do We Stand?

A. Schneider, A. Henriques, C. Pitzer, 2010, Front. Neurosci..

A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis

A. Echaniz-Laguna, J. Loeffler, A. Henriques, 2015, EMBO molecular medicine.

A plural role for lipids in motor neuron diseases: energy, signaling and structure

J. Loeffler, A. Henriques, L. Dupuis, 2013, Front. Cell. Neurosci..

Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.

P. Wong, V. Rasche, J. Kassubek, 2015, Human molecular genetics.

Longitudinal transcriptomic analysis of altered pathways in a CHMP2Bintron5-based model of ALS-FTD

J. Loeffler, A. Henriques, C. Keime, 2019, Neurobiology of Disease.

Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase

M. Spedding, A. Ludolph, A. Echaniz-Laguna, 2015, Human molecular genetics.

Necrosis, apoptosis, necroptosis, three modes of action of dopaminergic neuron neurotoxins

P. Poindron, N. Callizot, A. Henriques, 2019, PloS one.

GM1 Oligosaccharide Efficacy in Parkinson’s Disease: Protection against MPTP

E. Chiricozzi, Erika Di Biase, G. Lunghi, 2023, Biomedicines.

G-CSF protects motoneurons against axotomy-induced apoptotic death in neonatal mice

A. Henriques, L. Dupuis, C. Pitzer, 2010, BMC Neuroscience.

A Mechanism Underpinning the Bioenergetic Metabolism-Regulating Function of Gold Nanocatalysts

Z. Wang, R. Rossignol, N. Callizot, 2023, bioRxiv.

GM1 oligosaccharide efficacy against α-synuclein aggregation and toxicity in vitro.

M. Civera, F. Vasile, L. Zaccagnini, 2023, Biochimica et biophysica acta. Molecular and cell biology of lipids.

Low dietary protein content alleviates motor symptoms in mice with mutant dynactin/dynein-mediated neurodegeneration.

P. Wong, V. Rasche, J. Kassubek, 2015, Human Molecular Genetics.